The launch event for the Clinical Practice Guidelines for Home Nebulization Treatment of Respiratory Diseases in Children 2025, hosted by the China Health Promotion Foundation, was grandly held at the InterContinental Chengdu. Mr. Chen Xingping, Chairman of HOMED Medical Group, was invited to attend the conference.
The conference aims to focus on enhancing public respiratory health, strengthening prevention and management of respiratory diseases, advancing healthcare service systems, and promoting scientific innovation and clinical practice in related fields and we will address the challenges of chronic respiratory disease prevention and control, injecting new momentum into the development of public respiratory health initiatives. Renowned experts in respiratory medicine nationwide were invited to share insights on topics including home nebulization therapy for pediatric respiratory infections and challenges and solutions in preventing childhood wheezing. These discussions aim to continuously elevate the standards and effectiveness of comprehensive respiratory disease management, scientifically guiding efforts to jointly pioneer a new chapter in home nebulization therapy.
In treating respiratory infections in children, common misconceptions among parents include indiscriminate cough suppression and overuse of antibiotics. Over the past few years, home medication options have become increasingly diverse, with home nebulization emerging as a new choice and trend. It delivers medication directly to target organs, acts rapidly, causes fewer systemic side effects, and requires minimal cooperation from the child. Therefore, children with respiratory infections can undergo standardized home nebulization therapy as prescribed by a doctor.
JLN-2311HDD Plus, the pediatric-specific nebulizer brand under HOMED Medical, demonstrates exceptional professionalism and differentiation in the field of home nebulizers for children. The silicone face mask which is designed with a pacifier-grade silicone surface and its eco-friendly, safe, and securely for child's face in peace of mind. The machine operates at only 45 decibels, allowing children to sleep while receiving treatment. Its multi-stage filtration system ensures every breath is safe and clean. The 2.88-micron nebulized particles reach the affected areas in the lungs directly, delivering precise and effective treatment. This is precisely why the JLN-2311HDD Plus nebulizer is highly favored in hospitals, stands out in the market, and has earned excellent word-of-mouth among mothers, becoming the top choice for many families seeking nebulization therapy for their babies.
HOMED Medical has consistently strived to advance nebulization development in China. As early as 2013, it actively responded to President Xi Jinping's Belt and Road Initiative, emerging as a trailblazer in China's nebulization industry. In 2017, it pioneered the Smart Nebulization Center and contributed to the“Standardization and Regulatory Management of Pediatric Asthma Clinics,”enhancing pediatricians' skills. Leveraging robust academic expertise and clinical research, it has driven primary healthcare development by establishing over 4,000 nebulization centers nationwide, serving more than 500,000 outpatient visits daily. Today, we have once again pioneered the development of a pediatric-specific nebulizer (JLN-2311HDD Plus) and participated in the release of home nebulization guidelines, strengthening the dissemination of nebulization knowledge and promoting public awareness of nebulization therapy.We are committed to bringing nebulization into millions of households, wholeheartedly safeguarding the respiratory health of China's children!
